Mlp a-1

Name: MLP A-1

MLP A-1 Description

Bupivacaine hydrochloride is 2-Piperidinecarboxamide, 1-butyl-N-(2,6-dimethylphenyl)-, monohydrochloride, monohydrate, a white crystalline powder that is freely soluble in 95 percent ethanol, soluble in water, and slightly soluble in chloroform or acetone. It has the following structural formula:

Marcaine Structure

 

Epinephrine is (-)-3,4-Dihydroxy-α-[(methylamino)methyl] benzyl alcohol. It has the following structural formula:

Epinephrine Structure

 

MARCAINE is available in sterile isotonic solutions with and without epinephrine (as bitartrate) 1:200,000 for injection via local infiltration, peripheral nerve block, and caudal and lumbar epidural blocks. Solutions of MARCAINE may be autoclaved if they do not contain epinephrine. Solutions are clear and colorless.

Bupivacaine is related chemically and pharmacologically to the aminoacyl local anesthetics. It is a homologue of mepivacaine and is chemically related to lidocaine. All three of these anesthetics contain an amide linkage between the aromatic nucleus and the amino, or piperidine group. They differ in this respect from the procaine-type local anesthetics, which have an ester linkage.

MARCAINESterile isotonic solutions containing sodium chloride. In multiple-dose vials, each mL also contains 1 mg methylparaben as antiseptic preservative. The pH of these solutions is adjusted to between 4 and 6.5 with sodium hydroxide or hydrochloric acid.

MARCAINE with epinephrine 1:200,000 (as bitartrate)Sterile isotonic solutions containing sodium chloride. Each mL contains bupivacaine hydrochloride and 0.0091 mg epinephrine bitartrate, with 0.5 mg sodium metabisulfite, 0.001 mL monothioglycerol, and 2 mg ascorbic acid as antioxidants, 0.0017 mL 60% sodium lactate buffer, and 0.1 mg edetate calcium disodium as stabilizer. In multiple-dose vials, each mL also contains 1 mg methylparaben as antiseptic preservative. The pH of these solutions is adjusted to between 3.4 and 4.5 with sodium hydroxide or hydrochloric acid. The specific gravity of MARCAINE 0.5% with epinephrine 1:200,000 (as bitartrate) at 25°C is 1.008 and at 37°C is 1.008.

Indications and Usage for MLP A-1

MARCAINE is indicated for the production of local or regional anesthesia or analgesia for surgery, dental and oral surgery procedures, diagnostic and therapeutic procedures, and for obstetrical procedures. Only the 0.25% and 0.5% concentrations are indicated for obstetrical anesthesia. (See WARNINGS.)

Experience with nonobstetrical surgical procedures in pregnant patients is not sufficient to recommend use of 0.75% concentration of MARCAINE in these patients.

MARCAINE is not recommended for intravenous regional anesthesia (Bier Block). See WARNINGS.

The routes of administration and indicated MARCAINE concentrations are:

• local infiltration 0.25%
• peripheral nerve block 0.25% and 0.5%
• retrobulbar block 0.75%
• sympathetic block 0.25%
• lumbar epidural 0.25%, 0.5%, and 0.75% 
(0.75% not for obstetrical anesthesia)
• caudal 0.25% and 0.5%
• epidural test dose 0.5% with epinephrine 1:200,000
• dental blocks 0.5% with epinephrine 1:200,000

(See DOSAGE AND ADMINISTRATION for additional information.)

Standard textbooks should be consulted to determine the accepted procedures and techniques for the administration of MARCAINE.

Contraindications

MARCAINE is contraindicated in obstetrical paracervical block anesthesia. Its use in this technique has resulted in fetal bradycardia and death.

MARCAINE is contraindicated in patients with a known hypersensitivity to it or to any local anesthetic agent of the amide-type or to other components of MARCAINE solutions.

Lidocaine Hydrochloride

AQUEOUS SOLUTIONS FOR
INFILTRATION AND NERVE BLOCK

Ampul

Plastic Multiple-dose Fliptop Vial

Glass Teartop Vial

Rx only

Kenalog®-40

NOT FOR USE IN NEONATES 
CONTAINS BENZYL ALCOHOL

For Intramuscular or Intra-articular Use Only 
NOT FOR INTRAVENOUS, INTRADERMAL, INTRAOCULAR, EPIDURAL, OR INTRATHECAL USE

Purpose

Antiseptic

Use

antiseptic skin preparation

Principal Display Panel - MLP A-1 Kit

NDC 49836-740-01

RX-Only

MLP A-1

Kit Contains:

2 Kenalog-40® Single Dose Vial (1mL)
1 Marcaine® 0.5% Single Dose Vial (5mg/mL) (10mL)
1 Lidocaine HCl Injection, USP 2% Single Dose Ampule (20mg/mL) (2mL)
1 Sterile Povidone-Iodine Swabsticks (3 Swabs)
1 Pair Nitrile Powder Free Sterile Gloves (Size 7.5)
1 Sterile Towel Drape
1 Fenestrated Sterile Towel Drape
1 Sterile Adhesive Bandage
1 Pack of Sterile 4x4 Gauze (2 Gauzes)

1 Dose

Needles and Syringes Not Included

Distributed by:

DANEX INTERNATIONAL LLC
SPRING, TXl 77388

MANUFACTURED BY:

Rx
Pharma
Pack
HAUPPAUGE, NY 11788

Questions/Comments 1-844-632-7898

Kit Contents:

Kenalog-40® † (Bristol-Myers Squibb)*
Triamcinolone Acetonide Injectable Suspension, USP
Each mL Provides 40 mg triamcinolone acetonide with 0.65% sodium chloride for isotonicity, 0.99% (w/v) benzyl alcohol added as a preservative, 0.75% carboxymethylcellulose sodium, and 0.04% polysorbate 80 in an aqueous suspension; sodium hydroxide or hydrochloric acid may be present to adjust pH to 5.0-7.5.

Marcaine® ‡ 0.5% (5mg/mL) (Hospira, Inc.)*
Each mL contains 5mg bupivacaine HCl, with NaCl to make isotonic, in Water for Injection. pH adjusted with NaOH or HCl.

Lidocaine HCl Injection, USP 2% (20mg/mL) (Hospira, Inc.)*
Each mL contains lidocaine hydrochloride, anhydrous 20mg; sodium chloride 6mg. May contain sodium hydroxide and/or hydrochloric acid for pH adjustment. pH 6.5 (5.0 to 7.0). 0.31 mOsmol/mL (calc).

Sterile Povidone-lodine Swabsticks (Aplicare)*

Nitrile Powder Free Sterile Gloves (Dynarex) Size 7.5*

Sterile Towel Drape (Dynarex)*

Fenestrated Sterile Towel Drape (Dynarex)*

Sterile Adhesive Bandage (Dynarex)*

Sterile 4x4 Gauze (Dynarex)*

† Kenalog® (registered trademark of Bristol-Myers Squibb)

‡ Marcaine® (registered trademark of Hospira, Inc.)

* Internal package components remain sterile as long as items are unopened and undamaged

WARNING: KEEP THIS AND ALL MEDICATION OUT
OF THE REACH OF CHILDREN. IN CASE OF
ACCIDENTAL OVERDOSE, SEEK PROFESSIONAL
ASSISTANCE OR CONTACT A POISON CONTROL
CENTER IMMEDIATELY.

PROTECT FROM LIGHT I AVOID FREEZING

STORE AT CONTROLLED ROOM TEMPERATURE
20º-25ºC (68º-77º F) [SEE USP CONTROLLED
ROOM TEMPERATURE]

DO NOT REFRIGERATE.

Directions for Use: See enclosed inserts.

MLP A-1

MLP A-1 
bupivacaine hydrochloride, lidocaine hydrochloride, triamcinolone acetonide, and povidone-iodine kit
Product Information
Product Type HUMAN PRESCRIPTION DRUG LABEL Item Code (Source) NDC:49836-740
Packaging
# Item Code Package Description
1 NDC:49836-740-01 1 KIT in 1 PACKAGE, COMBINATION
Quantity of Parts
Part # Package Quantity Total Product Quantity
Part 1 1 VIAL, SINGLE-DOSE 10 mL
Part 2 1 AMPULE 2 mL
Part 3 2 VIAL, SINGLE-DOSE 2 mL
Part 4 1 PACKET 6.5 mL
Part 1 of 4
MARCAINE 
bupivacaine hydrochloride injection, solution
Product Information
Route of Administration EPIDURAL, INFILTRATION DEA Schedule     
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
BUPIVACAINE HYDROCHLORIDE (BUPIVACAINE) BUPIVACAINE HYDROCHLORIDE ANHYDROUS 5 mg  in 1 mL
Inactive Ingredients
Ingredient Name Strength
SODIUM CHLORIDE  
SODIUM HYDROXIDE  
HYDROCHLORIC ACID  
WATER  
Packaging
# Item Code Package Description
1 10 mL in 1 VIAL, SINGLE-DOSE
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA016964 10/03/1972
Part 2 of 4
LIDOCAINE HCL 
lidocaine hcl injection, solution
Product Information
Route of Administration EPIDURAL, INFILTRATION DEA Schedule     
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
LIDOCAINE HYDROCHLORIDE (LIDOCAINE) LIDOCAINE HYDROCHLORIDE ANHYDROUS 20 mg  in 1 mL
Inactive Ingredients
Ingredient Name Strength
SODIUM CHLORIDE 6 mg  in 1 mL
WATER  
SODIUM HYDROXIDE  
HYDROCHLORIC ACID  
Packaging
# Item Code Package Description
1 2 mL in 1 AMPULE
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA088294 05/16/1984
Part 3 of 4
KENALOG-40 
triamcinolone acetonide injection, suspension
Product Information
Route of Administration INTRA-ARTICULAR, INTRAMUSCULAR DEA Schedule     
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
TRIAMCINOLONE ACETONIDE (TRIAMCINOLONE ACETONIDE) TRIAMCINOLONE ACETONIDE 40 mg  in 1 mL
Inactive Ingredients
Ingredient Name Strength
SODIUM CHLORIDE  
BENZYL ALCOHOL  
CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM  
POLYSORBATE 80  
SODIUM HYDROXIDE  
HYDROCHLORIC ACID  
NITROGEN  
Packaging
# Item Code Package Description
1 2 VIAL, SINGLE-DOSE in 1 CARTON
1 1 mL in 1 VIAL, SINGLE-DOSE
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA014901 06/01/2009
Part 4 of 4
APLICARE POVIDONE-IODINE TRIPLES 
povidone-iodine solution
Product Information
Route of Administration TOPICAL DEA Schedule     
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
POVIDONE-IODINE (IODINE) IODINE 10 mg  in 1 mL
Inactive Ingredients
Ingredient Name Strength
SODIUM PHOSPHATE, DIBASIC  
CITRIC ACID MONOHYDRATE  
SODIUM HYDROXIDE  
NONOXYNOL-9  
WATER  
Packaging
# Item Code Package Description
1 6.5 mL in 1 PACKET
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
OTC MONOGRAPH NOT FINAL part333A 03/01/1998
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA014901 06/01/2009
Labeler - RX PHARMA-PACK, INC. (962149634)
Establishment
Name Address ID/FEI Operations
RX PHARMA-PACK, INC. 962149634 PACK(49836-740)
Revised: 10/2015   RX PHARMA-PACK, INC.
(web3)